Drug recall
Blood and Blood Products for Reprocessing
FDA recall event 85548 · Class II · Gulf Coast Regional Blood Center
Key facts
| Event ID | 85548 |
|---|---|
| Recall numbers | B-0471-2020, B-0472-2020 |
| Recalling firm | Gulf Coast Regional Blood Center |
| Product type | Biologics |
| Products | Blood and Blood Products for Reprocessing, Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Blood products, collected from a donor who was previously deferred for high risk behavior, were distributed. |
| Initiation date | Feb 19, 2020 |
| Report date | May 13, 2020 |
| Termination date | May 5, 2020 |
| City | Houston |
| State | TX |
| Country | United States |
| FEI number | 3002133806 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: